Margaret S. Collins

Cushion, Melanie T; Collins, Margaret S; Sesterhenn, Thomas; Porollo, Aleksey; Vadukoot, Anish Kizhakkekkara; Merino, Edward J 2016. Functional Characterization of Pneumocystis carinii Inositol Transporter 1. mBio, 7 6,

Porollo, Aleksey; Sesterhenn, Thomas M; Collins, Margaret S; Welge, Jeffrey A; Cushion, Melanie T 2014. Comparative genomics of pneumocystis species suggests the absence of genes for myo-inositol synthesis and reliance on inositol transport and metabolism. mBio, 5 6, e01834

Linke, Michael J; Ashbaugh, Alan; Collins, Margaret S; Lynch, Keeley; Cushion, Melanie T 2013. Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia. Infection and immunity, 81 3, 984-95

Maciejewska, Dorota; Zabinski, Jerzy; Ka?mierczak, Pawel; Rezler, Mateusz; Krassowska-?wiebocka, Barbara; Collins, Margaret S; Cushion, Melanie T 2012. Analogs of pentamidine as potential anti-Pneumocystis chemotherapeutics. European journal of medicinal chemistry, 48 , 164-73

Cushion, Melanie T; Collins, Margaret S 2011. Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrobial agents and chemotherapy, 55 10, 4513-8

Cushion, Melanie T; Linke, Michael J; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S; Lynch, Keeley; Brubaker, Ronald; Walzer, Peter D 2010. Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. PloS one, 5 1, e8524

Joffrion, Tiffany M; Collins, Margaret S; Sesterhenn, Thomas; Cushion, Melanie T 2010. Functional characterization and localization of Pneumocystis carinii lanosterol synthase. Eukaryotic cell, 9 1, 107-15

Cushion, Melanie T; Collins, Margaret S; Linke, Michael J 2009. Biofilm formation by Pneumocystis spp. Eukaryotic cell, 8 2, 197-206

Huang, Tien L; Vanden Eynde, Jean Jacques; Mayence, Annie; Collins, Margaret S; Cushion, Melanie T; Rattendi, Donna; Londono, Indira; Mazumder, Lakshman; Bacchi, Cyrus J; Yarlett, Nigel 2009. Synthesis and SAR of alkanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity. Bioorganic & medicinal chemistry letters, 19 20, 5884-6

Vale, Nuno; Prudêncio, Miguel; Marques, Catarina A; Collins, Margaret S; Gut, Jiri; Nogueira, Fátima; Matos, Joana; Rosenthal, Philip J; Cushion, Melanie T; do Rosário, Virgílio E; Mota, Maria M; Moreira, Rui; Gomes, Paula 2009. Imidazoquines as antimalarial and antipneumocystis agents. Journal of medicinal chemistry, 52 23, 7800-7

Mayence, Annie; Pietka, Aurélie; Collins, Margaret S; Cushion, Melanie T; Tekwani, Babu L; Huang, Tien L; Vanden Eynde, Jean Jacques 2008. Novel bisbenzimidazoles with antileishmanial effectiveness. Bioorganic & medicinal chemistry letters, 18 8, 2658-61

Vale, Nuno; Collins, Margaret S; Gut, Jiri; Ferraz, Ricardo; Rosenthal, Philip J; Cushion, Melanie T; Moreira, Rui; Gomes, Paula 2008. Anti-Pneumocystis carinii and antiplasmodial activities of primaquine-derived imidazolidin-4-ones. Bioorganic & medicinal chemistry letters, 18 2, 485-8

Joffrion, Tiffany M; Collins, Margaret S; Cushion, Melanie T 2006. Microaerophilic conditions increase viability and affect responses of Pneumocystis carinii to drugs in vitro. The Journal of eukaryotic microbiology, 53 Suppl 1 , S117-8

Cushion, Melanie T; Walzer, Peter D; Collins, Margaret S; Rebholz, Sandra; Vanden Eynde, Jean Jacques; Mayence, Annie; Huang, Tien L 2004. Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds. Antimicrobial agents and chemotherapy, 48 11, 4209-16

Vanden Eynde, Jean Jacques; Mayence, Annie; Huang, Tien L; Collins, Margaret S; Rebholz, Sandra; Walzer, Peter D; Cushion, Melanie T 2004. Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia. Bioorganic & medicinal chemistry letters, 14 17, 4545-8

Collins, Margaret S; Bansil, Sandeep; Cushion, Melanie T 2003. Expression profiling of the responses of Pneumocystis carinii to drug treatment using DNA macroarrays. The Journal of eukaryotic microbiology, 50 Suppl , 605-6

Icenhour, Crystal R; Rebholz, Sandra L; Collins, Margaret S; Cushion, Melanie T 2002. Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryotic cell, 1 3, 414-9

Zhou, Wenxu; Nguyen, Thi Thuy Minh; Collins, Margaret S; Cushion, Melanie T; Nes, W David 2002. Evidence for multiple sterol methyl transferase pathways in Pneumocystis carinii. Lipids, 37 12, 1177-86

Collins, M S; Cushion, M T 2001. Standardization of an in vitro drug screening assay by use of cryopreserved and characterized Pneumocystis carinii populations. The Journal of eukaryotic microbiology, Suppl , 178S-179S

Icenhour, C R; Rebholz, S L; Collins, M S; Cushion, M T 2001. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. Journal of clinical microbiology, 39 10, 3437-41

Icenhour, C R; Rebholz, S L; Collins, M S; Cushion, M T 2001. Early acquisition of Pneumocystis carinii in neonatal rats using targeted PCR and oral swabs. The Journal of eukaryotic microbiology, Suppl , 135S-136S

Kaneshiro, E S; Collins, M S; Cushion, M T 2000. Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. Antimicrobial agents and chemotherapy, 44 6, 1630-8